Cited by 106Regulation of Appetite and ObesityProtein Tyrosine PhosphatasesAdipokines, Inflammation, and Metabolic Diseases

Increased Hypothalamic Protein Tyrosine Phosphatase 1B Contributes to Leptin Resistance with Age

Open access
Morrison, Christopher D., White, Christy L., Wang, Zhong, Lee, Seung-Yub, Lawrence, David S., Cefalu, William T., Zhang, Zhong-Yin, Gettys, Thomas W.·2007·Endocrinology

Abstract

Animals at advanced ages exhibit a reduction in central leptin sensitivity. However, changes in growth, metabolism, and obesity risk occur much earlier in life, particularly during the transition from youth to middle age. To determine when initial decreases in central leptin sensitivity occur, leptin-dependent suppression of food intake was tested in 8-, 12-, and 20-wk-old male, chow-fed Sprague Dawley rats. Intracerebroventricular leptin injection (3 μg) suppressed 24-h food intake in 8- and 12-wk-old rats (P < 0.05) but not 20-wk-old rats. To identify potential cellular mediators of this resistance, we focused on protein tyrosine phosphatase 1B (PTP1B), a recently described inhibitor of leptin signaling. PTP1B protein levels, as determined by Western blot, were significantly higher in mediobasal hypothalamic punches collected from 20-wk-old rats, compared with 8-wk-old rats (P < 0.05). When 20-wk-old rats were fasted for 24 h, levels of hypothalamic PTP1B decreased (P < 0.05), coincident with a restoration of leptin sensitivity. To directly test whether inhibition of PTP1B restores leptin sensitivity, 20-wk-old chow-fed rats were pretreated with a pharmacological PTP1B inhibitor 1 h before leptin, and 24-h food intake was recorded. As expected, leptin alone produced a small but nonsignificant reduction in food intake. However, pretreatment with the PTP1B inhibitor resulted in a marked improvement in leptin-dependent suppression of food intake (P < 0.05). These data are consistent with the hypothesis that increases in PTP1B contribute to hypothalamic leptin resistance as rats transition into middle age.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/en.2006-0672

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Morrison, C. D., White, C. L., Wang, Z., Lee, S.-Y., Lawrence, D. S., Cefalu, W. T., Zhang, Z.-Y., & Gettys, T. W.
Affiliations
  • Pennington Biomedical Research Center (US)
  • Stony Brook University (US)
  • Albert Einstein College of Medicine (US)
  • Indiana University Indianapolis (US)
Corresponding author
Morrison, Christopher D.
Venue
Endocrinology
Published
2007-01-01
Volume
148
Issue
1
Pages
433-440
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W2133447451
Cited by
106
References
46
Citations by year
2026: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2020: 2 · 2019: 4 · 2018: 7 · 2017: 4 · 2016: 6 · 2015: 8 · 2014: 14 · 2013: 9 · 2012: 9
FWCI
2.94
Type
journal article
Language
en
Open access
Locations
  • Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • IUScholarWorks (Indiana University) (submittedVersion)
Funders
  • American Diabetes Association
  • National Institutes of Health
  • National Institute of General Medical Sciences (P30GM118430)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK074772, DK068447, R01DK068447, R01DK074772, P30DK072476)
  • National Institute of Neurological Disorders and Stroke (NS-051570, R03NS051570)
  • National Center for Research Resources (P20RR021945)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
Keywords
leptin resistance, PTP1B, hypothalamus, aging, feeding inhibition, leptin signaling, PTP1B inhibitors, fasting, mediobasal hypothalamus
MeSH terms
Aging, Animals, Eating, Enzyme Inhibitors, Fasting, Hypothalamus, Male, Obesity, Protein Tyrosine Phosphatases, Rats, Sprague-Dawley, Leptin, Rats, Janus Kinase 2, Protein Tyrosine Phosphatase, Non-Receptor Type 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review